HLS THERAPEUTICS

Pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes, cardiovascular disorders, central nervous system (CNS) disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, respiratory, gastrointestinal and other metabolic disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, osteoporosis and other bone disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, immunomodulatory diseases, namely, autoimmune diseases, immunologic deficiency syndromes; and antidepressants, antivirals, antibacterial pharmaceuticals, antifungal preparations, anti-inflammatories, analgesics and other pain therapeutics, namely, pain relief medications in the nature of muscle relaxants, anti-anxiety and anti-convulsion medications and acetaminophen, pharmaceutical preparations to treat diseases of the genitourinary system in women, hormones, namely, progesterone, progestins, and estrogens, hormone receptor modulators, and osteoporosis medicines

Pharmaceutical drug formulation development; clinical evaluation and testing in the nature of conducting clinical trials relating to pharmaceuticals